Comparative Analysis of Tyrosine tRNA (MT-TY) Gene Mutation Related to Lung Cancer Patients from District Peshawar, Khyber-Pakhtunkhwa, Pakistan During 2020-2022: Analysis of Tyrosine tRNA (MT-TY) Gene Mutation

Zeeshan  Abbas; Saira  Aslam; Muhammad  Nabeel; Fatima  Habib

doi:10.54393/pbmj.v6i08.928

Authors

Zeeshan Abbas Department of Biotechnology and Genetic Engineering, Hazara University, Mansehra, Pakistan
Saira Aslam University of Veterinary and Animal Sciences, Lahore, Pakistan
Muhammad Nabeel Hazara University, Mansehra, Pakistan
Fatima Habib Department of Zoology, Sargodha University, Sargodha, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v6i08.928

Keywords:

MT-TY, Gene Mutation, Lung Cancer

Abstract

The uncontrolled growth of cells in the lungs is called lung cancer (LC). Majority of recorded LC cases is as a result of cigarette smoking. It is one of the most occurring types of cancer around the globe. Objective: To emphasizes on amplification of specific mitochondrial DNA (mtDNA) genes coding for tyrosine tRNA and to find out its association with LC patients of Peshawar. Methods: In 18 LC patients, the mitochondrially encoded tRNA tyrosine gene was studied. Samples were collected from the Institute of Radiotherapy & Nuclear Medicine (IRNUM), Peshawar, Khyber Pakhtunkhwa. The participants varied in age from 12 to 86 years. Patients had diabetes, hypertension, hepatitis C, bronchial asthma, dyspnea, hemoptysis, cardio myopathy, and stomach ulcers. DNA extraction and PCR of the tyr tRNA gene were performed. Along with gel electrophoresis. 8 samples were cleaned and sequenced. Results: The results were used for comparison with the reference DNA sequence of mitochondria i.e., revised Cambridge Reference Sequence (rCRS) Accession No 0129201. According to NCBI BLAST data, there were no variations in the nucleotide position 5826-5891 of the mitochondrially encoded tyrosine tRNA gene in LC subject. Chromatogram of tyrosine gene which was taken from UGENE software showed that there is no variation in Tyrosine gene subject sequence. Conclusions: We found no mutation in the mtDNA encoded tyr tRNA gene related to LC patient from District Peshawar Khyber-Pakhtunkhwa, Pakistan during 2020-2022.

References

Maisaini M, Uzun B, Ozsahin I, Uzun D. Evaluating lung cancer treatment techniques using fuzzy PROMETHEE approach. In13th International Conference on Theory and Application of Fuzzy Systems and Soft Computing—ICAFS-2018-13. Springer International Publishing. 2019. doi: 10.1007/978-3-030-04164-9_29. DOI: https://doi.org/10.1007/978-3-030-04164-9_29

Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell. 2002 Feb; 1(1): 49-52. doi: 10.1016/S1535-6108(02)00027-2. DOI: https://doi.org/10.1016/S1535-6108(02)00027-2

Shang JL, Ning SB, Chen YY, Chen TX, Zhang J. MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer. Acta Pharmacologica Sinica. 2021 Jan; 42(1): 120-31. doi: 10.1038/s41401-020-0442-2. DOI: https://doi.org/10.1038/s41401-020-0442-2

Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. InMayo clinic proceedings. 2008 May; 83(5): 584-94. doi: 10.1016/S0025-6196(11)60735-0. DOI: https://doi.org/10.1016/S0025-6196(11)60735-0

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015 Mar; 136(5): E359-86. doi: 10.1002/ijc.29210. DOI: https://doi.org/10.1002/ijc.29210

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. Ca: A Cancer Journal of Clinicians. 2021 Jan; 71(1): 7-33. doi: 10.3322/caac.21654. DOI: https://doi.org/10.3322/caac.21654

Lippman SM and Spitz MR. Lung cancer chemoprevention: an integrated approach. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2001 Sep; 19(18 Suppl): 74S-82S.

Amos CI, Xu W, Spitz MR. Is there a genetic basis for lung cancer susceptibility? Chemoprevention of Cancer: A Clinical Update. 1999: 3-12. doi: 10.1007/978-3-642-59945-3_1. DOI: https://doi.org/10.1007/978-3-642-59945-3_1

Li H, Zhao M, Fei G, Wang Z, Wang S, Wei P, et al. Epidemiological trends and incidence prediction of lung cancer in China based on the Global Burden of Disease study 2019. Frontiers in Medicine. 2022 Sep; 9: 969487. doi: 10.3389/fmed.2022.969487. DOI: https://doi.org/10.3389/fmed.2022.969487

Majeed FA, Azeem AR, Farhan N. Lung cancer in Pakistan, where do we stand. JPMA. 2019 Mar; 69(3): 405-8.

Ali A, Manzoor MF, Ahmad N, Aadil RM, Qin H, Siddique R, et al. The burden of cancer, government strategic policies, and challenges in Pakistan: A comprehensive review. Frontiers in nutrition. 2022 Jul; 9: 940514. doi: 10.3389/fnut.2022.940514. DOI: https://doi.org/10.3389/fnut.2022.940514

Fong KM, Sekido Y, Minna JD. The molecular basis of lung carcinogenesis. In The molecular basis of human cancer. Totowa, NJ: Humana Press. 2002: 379-405. doi: 10.1007/978-1-59259-125-1_17. DOI: https://doi.org/10.1007/978-1-59259-125-1_17

Chuang KY, Chuang YC, Ho YS. Global influence of Cancer Statistics articles. Current Science. 2015 Nov; 109(9): 1552-4.

Navada S, Lai P, Schwartz AG, Kalemkerian GP. Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database. Journal of Clinical Oncology. 2006 Jun; 24(18_suppl): 7082. doi: 10.1200/jco.2006.24.18_suppl.7082. DOI: https://doi.org/10.1200/jco.2006.24.18_suppl.7082

Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. Journal of Biomolecular Techniques: JBT. 2013 Dec; 24(4): 224. doi: 10.7171/jbt.13-2404-001. DOI: https://doi.org/10.7171/jbt.13-2404-001

Gupta N. DNA extraction and polymerase chain reaction. Journal of Cytology. 2019 Apr; 36(2): 116-7. doi: 10.4103/JOC.JOC_110_18. DOI: https://doi.org/10.4103/JOC.JOC_110_18

Ozmen S and Ceylan O. Trends in lung cancer incidence within the last 10 years: An Eastern Anatolian single center experience. Journal of Surgery and Medicine. 2020 Feb; 4(2): 112-5. DOI: https://doi.org/10.28982/josam.683464

Yatabe Y, Dacic S, Borczuk AC, Warth A, Russell PA, Lantuejoul S, et al. Best practices recommendations for diagnostic immunohistochemistry in lung cancer. Journal of Thoracic Oncology. 2019 Mar; 14(3): 377-407. doi: 10.1016/j.jtho.2018.12.005. DOI: https://doi.org/10.1016/j.jtho.2018.12.005

Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, et al. Mitochondrial diseases. Nature reviews Disease primers. 2016 Oct; 2(1): 1-22. doi: 10.1038/nrdp.2016.80. DOI: https://doi.org/10.1038/nrdp.2016.80

Korpanty GJ, Graham DM, Vincent MD, Leighl NB. Biomarkers that currently affect clinical practice in lung cancer: EGFR, ALK, MET, ROS-1, and KRAS. Frontiers in Oncology. 2014 Aug; 4: 204. doi: 10.3389/fonc.2014.00204. DOI: https://doi.org/10.3389/fonc.2014.00204

Bandelt HJ, Kloss-Brandstätter A, Richards MB, Yao YG, Logan I. The case for the continuing use of the revised Cambridge Reference Sequence (rCRS) and the standardization of notation in human mitochondrial DNA studies. Journal of Human Genetics. 2014 Feb; 59(2): 66-77. doi: 10.1038/jhg.2013.120. DOI: https://doi.org/10.1038/jhg.2013.120

Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nature Reviews Genetics. 2012 Dec; 13(12): 878-90. doi: 10.1038/nrg3275. DOI: https://doi.org/10.1038/nrg3275

Kripps KA, Friederich MW, Chen T, Larson AA, Mirsky DM, Wang Y, et al. A novel acceptor stem variant in mitochondrial tRNATyr impairs mitochondrial translation and is associated with a severe phenotype. Molecular Genetic and Metabolism. 2020 Dec; 131(4): 398-404. doi: 10.1016/j.ymgme.2020.11.006. DOI: https://doi.org/10.1016/j.ymgme.2020.11.006